2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules

Area of Science:

• Pharmacology
• Cell Biology
• Oncology

Background:

• 2-Methoxyestradiol (2ME2), an estradiol metabolite, is an investigational antimitotic and antiangiogenic agent.
• 2ME2's proposed mechanism involves binding to tubulin and inhibiting microtubule polymerization, but its precise role in mitotic arrest is debated.

Purpose of the Study:

• To elucidate the mechanism by which 2ME2 induces mitotic arrest.
• To investigate the effects of 2ME2 on microtubule polymerization and dynamic instability in vitro and in living cells.

Main Methods:

• In vitro tubulin polymerization assays with purified tubulin and microtubule-associated protein-containing microtubules.
• In vitro and live-cell (MCF7) analysis of microtubule dynamic instability.
• Determination of IC50 for mitotic arrest in MCF7 cells.

Main Results:

• 2ME2 inhibited purified tubulin assembly in a dose-dependent manner in vitro.
• Higher 2ME2 concentrations were needed to depolymerize microtubules in the presence of microtubule-associated proteins.
• 2ME2 suppressed microtubule growth rate and dynamicity in vitro and in living MCF7 cells at the IC50 for mitotic arrest, without causing significant depolymerization.

Conclusions:

• The primary mechanism of 2ME2-induced mitotic arrest at low concentrations is the suppression of microtubule dynamics.
• Microtubule depolymerization is not the main driver of 2ME2's antimitotic effect at therapeutically relevant concentrations.